39 results on '"Al-Jumayli, Mohammed A."'
Search Results
2. Support Through Remote Observation and Nutrition Guidance (STRONG), a digital health intervention to reduce malnutrition among pancreatic cancer patients: A study protocol for a pilot randomized controlled trial
3. Safety and efficacy of anti-BCMA CAR-T cell therapy in older adults with multiple myeloma: A systematic review and meta-analysis
4. Elevation of cancer antigen 15-3 owing to oncocytic renal neoplasm in a patient without evidence of breast cancer recurrence on follow-up: a case report
5. The Biological Process of Aging and the Impact of Ionizing Radiation
6. Predictors of Toxicity Among Older Adults with Cancer
7. Simple Score of Albumin and CRP Predicts High-Grade Toxicity in Patients with Multiple Myeloma Receiving CAR-T Therapy
8. Biologics, Immunotherapy, and Future Directions in the Treatment of Advanced Cholangiocarcinoma
9. CAR T-cell therapy has comparable efficacy with autologous transplantation in older adults with DLBCL in partial response
10. Safety and efficacy of anti-BCMA CAR-T cell therapy in older adults with multiple myeloma: A systematic review and meta-analysis
11. Biologic and Immunotherapy Developments in Advanced Hepatocellular Carcinoma
12. Beyond Frailty Phenotype, the role of Preoperative Electronic Frailty Assessment in Predicting Postoperative Outcomes in Older Patients Undergoing Surgery for Gastrointestinal Cancer: A Systematic Review
13. Evaluation of Employment Loss and Financial Hardship Among US Adults With Disabilities During the COVID-19 Pandemic
14. Clinical trial knowledge among U.S. adults aged 65 years and up: Findings from a 2020 national survey
15. Oncogeriatric Developments
16. Integration of geriatric assessment in cancer care for senior adults during COVID-19 pandemic.
17. Pre-operative Carboplatin/Paclitaxel Versus 5-Fluorouracil (5-FU)-based Chemoradiotherapy for Older Adults With Esophageal Cancer
18. Black Disparities in Targeted Therapy Clinical Trials – A Call for Future Reset
19. Exceptional response to Erlotinib monotherapy in EGFR Exon 19-deleted, KRAS wild-type, Chemo-refractory advanced pancreatic adenocarcinoma
20. Update on the Role of Poly (ADP-Ribose) Polymerase Inhibitors in the DNA Repair-Deficient Pancreatic Cancers: A Narrative Review
21. 221 Poor performance status negatively affects survival benefit of immunotherapy in non-small cell lung cancer
22. Clinical Outcomes of Different Treatment Modalities in Anaplastic Thyroid Cancer: A Single Center Experience
23. Immune Checkpoint Inhibitors versus VEGF Targeted Therapy as Second Line Regimen in Advanced Hepatocellular Carcinoma (HCC): A Retrospective Study
24. Abstract 2026: Outcomes in elderly patients with non-small-cell lung cancer receiving immune checkpoint inhibitor therapy: A real world experience
25. Immuno-Oncotherapeutic Approaches in Advanced Hepatocellular Carcinoma
26. Neoadjuvant cisplatin based therapy in bladder cancer: Is less enough?
27. Immunotherapy versus biologics as second-line therapy in advanced hepatocellular carcinoma (HCC).
28. Clinical Outcomes of Different Treatment Modalities in Anaplastic Thyroid Cancer: A Single Center Experience.
29. Abstract B29: Outcomes of DNA repair-deficient pancreatic cancers: KU Cancer Center experience
30. 126 Association Between Sessile Serrated Adenoma and Extra-colonic Malignancies
31. Potential interaction of radiation therapy, antibiotic, and steroid use in non-small cell lung cancer patients treated with checkpoint inhibitors: A retrospective analysis.
32. Clinical Outcome of Ampullary Carcinoma: Single Cancer Center Experience
33. The association of 5FU-based chemotherapy with pathological response or survival compared to carbo/taxol with locally advanced resectable esophageal cancer.
34. Clinical outcomes of early-stage ampullary carcinoma: KU Cancer Center experience.
35. Biologic and Immunotherapy Developments in Advanced Hepatocellular Carcinoma
36. Outcomes of pancreatic malignancy in octogenarians: A single tertiary center experience.
37. Association of frailty and high-risk immuno-nutritional score with outcomes in patients with relapsed and refractory multiple myeloma treated with chimeric antigen receptor T-cells.
38. Factors Associated With Focal Lamina Cribrosa Defects in Glaucoma
39. PRETREATMENT METHYLATION-BASED BIOLOGICAL AGE IS A NOVEL RISK FACTOR FOR TRASTUZUMAB-INDUCED CARDIOTOXICITY.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.